Loading clinical trials...
Loading clinical trials...
Evaluation of the Impact of Lock Down and End of Lock Down on the Management of Patients With Inflammatory and Dysimmune Diseases Followed in the Context of IMMINeNT FHU (Rheumatology, Dermatology, Internal Medicine, Pneumology, Gastroenterology, Neurology).
Conditions
Locations
1
France
Hop Claude Huriez Chu Lille
Lille, France
Start Date
July 21, 2020
Primary Completion Date
August 27, 2020
Completion Date
August 27, 2020
Last Updated
March 15, 2021
NCT01143454
NCT06275477
NCT04698291
NCT04525716
NCT03188796
NCT05860400
Lead Sponsor
University Hospital, Lille
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions